Scientists have reported the first successful case of an RNA‑targeting therapy improving symptoms in a patient with a rare form of ALS. The treatment uses gene‑targeting mechanisms to slow disease progression, offering hope for similar therapies for other neurodegenerative disorders. Researchers call this a milestone in personalized RNA medicine.
About the Author
